Court Place Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Court Place Advisors’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$914K	Sell	5,158 -100	-2%	-$14.9K	0.28%	70
2025 Q2	$598K	Sell	5,258 -50	-0.9%	-$5.34K	0.19%	85
2025 Q1	$558K	Sell	5,308 -475	-8%	-$53.7K	0.19%	88
2024 Q4	$620K	Sell	5,783 -7,700	-57%	-$870K	0.2%	83
2024 Q3	$1.35M	Sell	13,483 -725	-5%	-$73K	0.39%	56
2024 Q2	$1.2M	Buy	14,208 +6,475	+84%	+$515K	0.38%	60
2024 Q1	$565K	Sell	7,733 -7,300	-49%	-$538K	0.18%	91
2023 Q4	$1.07M	Sell	15,033 -100	-0.7%	-$5.9K	0.35%	67
2023 Q3	$907K	Hold	15,133	–	–	0.32%	72
2023 Q2	$1.09M	Sell	15,133 -400	-3%	-$30K	0.38%	63
2023 Q1	$1.14M	Hold	15,533	–	–	0.41%	63
2022 Q4	$1.04M	Sell	15,533 -9,366	-38%	-$609K	0.38%	68
2022 Q3	$1.34M	Sell	24,899 -321	-1%	-$18.9K	0.54%	50
2022 Q2	$1.4M	Hold	25,220	–	–	0.53%	51
2022 Q1	$1.77M	Hold	25,220	–	–	0.57%	46
2021 Q4	$2.43M	Hold	25,220	–	–	0.67%	43
2021 Q3	$2.19M	Sell	25,220 -184	-0.7%	-$14.2K	0.65%	45
2021 Q2	$2.08M	Sell	25,404 -161	-0.6%	-$13.4K	0.61%	47
2021 Q1	$2.43M	Sell	25,565 -481	-2%	-$45.5K	0.75%	40
2020 Q4	$1.62M	Sell	26,046 -160	-0.6%	-$9.12K	0.54%	50
2020 Q3	$1.56M	Buy	26,206 +1,808	+7%	+$123K	0.58%	48
2020 Q2	$1.7M	Sell	24,398 -240	-1%	-$15.2K	0.66%	41
2020 Q1	$1.12M	Sell	24,638 -112	-0.5%	-$6.35K	0.5%	52
2019 Q4	$1.61M	Hold	24,750	–	–	0.58%	44
2019 Q3	$1.54M	Sell	24,750 -217	-0.9%	-$13.6K	0.6%	42
2019 Q2	$1.78M	Sell	24,967 -120	-0.5%	-$8.84K	0.7%	38
2019 Q1	$1.97M	Hold	25,087	–	–	0.79%	34
2018 Q4	$2.12M	Buy	25,087 +417	+2%	+$44.5K	0.97%	30
2018 Q3	$4.22M	Sell	24,670 -4,368	-15%	-$659K	1.6%	16
2018 Q2	$3.75M	Sell	29,038 -2,283	-7%	-$255K	1.56%	17
2018 Q1	$3.23M	Sell	31,321 -601	-2%	-$59.4K	1.35%	20
2017 Q4	$2.73M	Sell	31,922 -2,870	-8%	-$249K	1.13%	28
2017 Q3	$2.96M	Sell	34,792 -224	-0.6%	-$17.7K	1.32%	21
2017 Q2	$2.65M	Sell	35,016 -40	-0.1%	-$2.8K	1.26%	24
2017 Q1	$2.31M	Buy	35,056 +160	+0.5%	+$10.5K	1.14%	27
2016 Q4	$2.21M	Buy	34,896 +722	+2%	+$45.6K	1.15%	27
2016 Q3	$2.18M	Buy	34,174 +913	+3%	+$67K	1.21%	24
2016 Q2	$2.48M	Hold	33,261	–	–	1.43%	22
2016 Q1	$2.22M	Buy	33,261 +481	+1%	+$29.2K	1.37%	21
2015 Q4	$2.22M	Hold	32,780	–	–	1.42%	19
2015 Q3	$1.75M	Sell	32,780 -400	-1%	-$24.3K	1.21%	26
2015 Q2	$2.09M	Hold	33,180	–	–	1.33%	23
2015 Q1	$1.6M	Hold	33,180	–	–	1.02%	31
2014 Q4	$1.1M	Buy	33,180 +4,087	+14%	+$133K	0.71%	42
2014 Q3	$853K	Hold	29,093	–	–	0.58%	47
2014 Q2	$1.13M	Sell	29,093 -6,893	-19%	-$280K	0.78%	41
2014 Q1	$1.51M	Buy	35,986 +616	+2%	+$25.7K	1.1%	31
2013 Q4	$1.16M	Buy	+35,370	New	+$1.15M	0.89%	40

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Court Place Advisors's LGND Position: Q3 2025 in Review

Court Place Advisors reduced its Ligand Pharmaceuticals (LGND) stake by 1.9% in Q3 2025, selling an estimated $14.9K and leaving 5,158 shares worth $914K. The position accounts for 0.28% of the portfolio, ranked #70.

Court Place Advisors first reported a position in LGND in Q4 2013 and has held it in 48 quarters since. The position peaked at $4.22M in Q3 2018. 314 funds tracked by Wall St. Rank hold LGND as of Q3 2025.

Court Place Advisors held 5,158 shares of Ligand Pharmaceuticals worth $914K as of Q3 2025.
Court Place Advisors sold 100 Ligand Pharmaceuticals shares in Q3 2025, an estimated $14.9K.
Ligand Pharmaceuticals made up 0.28% of Court Place Advisors's portfolio in Q3 2025, its #70 holding.
Court Place Advisors first reported a position in Ligand Pharmaceuticals in Q4 2013 and has held it in 48 quarters since.
Court Place Advisors's Ligand Pharmaceuticals position peaked at $4.22M in Q3 2018.
314 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2025.

Based on Court Place Advisors's 13F filing for Q3 2025, filed 25 Nov 2025.